Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1800014725Phase 4Not yet recruiting
Phase 4, randomised, single-blind trial of si jun zi tang in spleen qi deficiency (3 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: TCM syndrome score at week 4. Planned start Mar 2018; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1800014725.